SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-034524
Filing Date
2012-05-08
Accepted
2012-05-08 16:45:33
Documents
13
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a12-8599_110q.htm 10-Q 545640
2 EX-10.1 a12-8599_1ex10d1.htm EX-10.1 59551
3 EX-10.2 a12-8599_1ex10d2.htm EX-10.2 58319
4 EX-31.1 a12-8599_1ex31d1.htm EX-31.1 10284
5 EX-31.2 a12-8599_1ex31d2.htm EX-31.2 10585
6 EX-32.1 a12-8599_1ex32d1.htm EX-32.1 5624
7 EX-32.2 a12-8599_1ex32d2.htm EX-32.2 6107
  Complete submission text file 0001104659-12-034524.txt   2132536

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT bpax-20120331.xml EX-101.INS 146915
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bpax-20120331.xsd EX-101.SCH 18547
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bpax-20120331_cal.xml EX-101.CAL 34104
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bpax-20120331_def.xml EX-101.DEF 101822
12 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bpax-20120331_lab.xml EX-101.LAB 270022
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bpax-20120331_pre.xml EX-101.PRE 137209
Mailing Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 12821998
SIC: 2836 Biological Products, (No Diagnostic Substances)